SERUM ERYTHROPOIETIN (SEPO) TESTING, LEVELS, AND SUBSEQUENT TREATMENT PATTERNS FOR TRANSFUSION-DEPENDENT PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)

被引：0
|
作者：
Gerds, A. [1 ]
Binder, G. [2 ]
Fliss, A. [2 ]
McGuire, M. [2 ]
Hawthorne, S. [3 ]
King-Concialdi, K. [3 ]
DiBonaventura, M. [3 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
[2] Celgene Corp, Summit, NJ USA
[3] Kantar Hlth, New York, NY USA
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1917
引用
收藏
页码：772 / 773
页数：2
相关论文
共 50 条
  • [21] Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes
    Gattermann, Norbert
    Finelli, Carlo
    Della Porta, Matteo
    Fenaux, Pierre
    Stadler, Michael
    Guerci-Bresler, Agnes
    Schmid, Mathias
    Taylor, Kerry
    Vassilieff, Dominique
    Habr, Dany
    Marcellari, Andrea
    Roubert, Bernard
    Rose, Christian
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (09): : 1364 - 1371
  • [22] Deferiprone is useful in blood transfusion-dependent patients affected by myelodysplastic syndrome (MDS)
    Russolillo, S.
    Izzo, G. Nitrato
    Esposito, M.
    Improta, S.
    Lucania, A.
    Villa, M. R.
    Mastrullo, L.
    LEUKEMIA RESEARCH, 2007, 31 : S137 - S137
  • [23] Efficacy and safety of deferasirox (Exjade®) in chelation-naive and previously chelated patients with transfusion-dependent myelodysplastic syndromes (MDS)
    Schmid, M.
    Guerci-Bresler, A.
    Della Porta, M.
    Taylor, K.
    Habr, D.
    Domokos, G.
    Roubert, B.
    Rose, C.
    Gattermann, N.
    LEUKEMIA RESEARCH, 2009, 33 : S141 - S142
  • [24] Distribution of serum erythropoietin levels in Japanese patients with myelodysplastic syndromes
    Takahiro Suzuki
    Iekuni Oh
    Ken Ohmine
    Akiko Meguro
    Masaki Mori
    Shin-ichiro Fujiwara
    Chihiro Yamamoto
    Tadashi Nagai
    Keiya Ozawa
    International Journal of Hematology, 2015, 101 : 32 - 36
  • [25] Distribution of serum erythropoietin levels in Japanese patients with myelodysplastic syndromes
    Suzuki, Takahiro
    Oh, Iekuni
    Ohmine, Ken
    Meguro, Akiko
    Mori, Masaki
    Fujiwara, Shin-ichiro
    Yamamoto, Chihiro
    Nagai, Tadashi
    Ozawa, Keiya
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (01) : 32 - 36
  • [26] Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO study
    Sarocchi, Matteo
    Li, Junmin
    Li, Xiao
    Wu, Depei
    Figueroa, Efreen Montano
    Rodriguez, Maria Guadalupe
    Hou, Ming
    Finelli, Carlo
    Shi, Hong-Xia
    Xiao, Zhijian
    Oliva, Esther Natalie
    Kyuchukova, Liana Gercheva
    Drummond, Mark
    Symeonidis, Argiris
    Velazquez, Eric J.
    Rivoli, Giulia
    Izquierdo, Miguel
    Kolekar, Yogita
    Spallarossa, Paolo
    Angelucci, Emanuele
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (05) : 2049 - 2056
  • [27] Deferasirox (Exjade®) Is Effective and Well Tolerated in Chelation-Naive and Previously Chelated Patients with Transfusion-Dependent Myelodysplastic Syndromes (MDS)
    Schmid, Mathias
    Guerci-Bresler, Agnes
    Della Porta, Matteo
    Taylor, Kerry
    Habr, Dany
    Domokos, Gabor
    Roubert, Bernard
    Rose, Christian
    Gattermann, Norbert
    BLOOD, 2009, 114 (22) : 1464 - 1464
  • [28] IRON OVERLOAD AND IRON CHELATION THERAPY WITH DEFERASIROX IN TRANSFUSION-DEPENDENT PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    Del Corso, L.
    Bacigalupo, A.
    Balleari, E.
    Bellodi, A.
    Calzamiglia, T.
    Da Col, A.
    D'elia, P.
    Dominietto, A.
    Favorini, S.
    Forni, G.
    Galimberti, S.
    Ghio, M.
    Ghio, R.
    Salvetti, C.
    Ubezio, G.
    Vignolo, L.
    Molinari, E.
    Ghiso, A.
    Drousseau, M.
    Simonetti, F.
    Goretti, R.
    Tassara, R.
    Racchi, O.
    Scudeletti, M.
    Arboscello, E.
    Gianluca, F.
    LEUKEMIA RESEARCH, 2015, 39 : S150 - S150
  • [29] Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes
    Garcia-Manero, Guillermo
    Diez-Campelo, Maria
    Vellenga, Edo
    Jacoby, Meagan A.
    Merchan, Brayan
    Breems, Dimitri
    Cortelezzi, Agostino
    Doronin, Vadim
    Gomez, Valle
    Beckers, Marielle
    Della Porta, Matteo Giovanni
    Varsos, Helen
    Xiu, Liang
    DeAngelis, Nikki
    Nnane, Ivo
    Rose, Esther
    van Eygen, Koen
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (04) : E111 - E114
  • [30] Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone
    Musto, P
    Sanpaolo, G
    D'Arena, G
    Scalzulli, PR
    Matera, R
    Falcone, A
    Bodenizza, C
    Perla, G
    Carotenuto, M
    HAEMATOLOGICA, 2001, 86 (01) : 44 - 51
12345